Claims
- 1. A dyeing composition for dyeing keratinous fibres, in particular human keratinous fibres such as hair, comprising, in an appropriate dyeing medium, at least one cationic tertiary para-phenylenediamine containing a pyrrolidine ring, at least one non-cationic tertiary para-phenylenediamine, and at least one benzomorpholine coupler.
- 2. The composition of claim 1, wherein the cationic tertiary para-phenylenediamine corresponds to formula I:
- 3. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that n is equal to 0.
- 4. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that n is equal to 1 and R1 is chosen from the group consisting of a halogen atom; a saturated or unsaturated, aliphatic or alicylic, C1-C6 hydrocarbon chain; it being possible for one or more carbon atoms to be replaced by an oxygen, nitrogen, silicon or sulphur atom, or by an SO2 group, the radical R1 not containing a peroxide bond, or diazo, nitro or nitroso radicals.
- 5. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that R1 is chosen from chlorine, bromine, C1-C4 alkyl, C1-C4 hydroxyalkyl, C1-C4 aminoalkyl, C1-C4 alkoxy or C1-C4 hydroxyalkoxy radicals.
- 6. The composition of claim 5, in which the cationic tertiary para-phenylenediamine is such that R1 is chosen from a methyl, hydroxymethyl, 2-hydroxyethyl, 1,2-dihydroxyethyl, methoxy, isopropyloxy or 2-hydroxyethoxy radical.
- 7. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that R2 represents the onium radical Z corresponding to formula (II)
- 8. The composition of claim 7, wherein the cationic tertiary para-phenylenediamine is such that R2 corresponds to formula II in which x is equal to 0 and R4, R5 and R6 separately are preferably chosen from a C1-C6 alkyl radical, a C1-C4 monohydroxyalkyl radical, a C2-C4 polyhydroxyalkyl radical, a (C1-C6)alkoxy(C1-C4)alkyl radical, a C1-C6 amidoalkyl radical, a tri(C1-C6)alkylsilane(C1-C6)alkyl radical, or R4 with R5 form together an azetidine ring, a pyrrolidine, piperidine, piperazine or morpholine ring, R6 being chosen in this case from a C1-C6 alkyl radical; a C1-C6 monohydroxyalkyl radical, a C2-C6 polyhydroxyalkyl radical; a C1-C6 aminoalkyl radical, an aminoalkyl radical which is mono- or di-substituted with a (C1-C6)alkyl radical, a (C1-C6)alkylcarbonyl, amido or (C1-C6)alkylsulphonyl radical; a C1-C6 carbamylalkyl radical; a tri(C1-C6)alkylsilane(C1-C6)alkyl radical; a (C1-C6)alkyl carboxy(C1-C6)alkyl radical; a (C1-C6)alkylcarbonyl(C1-C6)alkyl radical; an N—(C1-C6)alkylcarbamyl(C1-C6)alkyl radical.
- 9. The composition of claim 7, wherein the cationic tertiary para-phenylenediamine is such that R2 corresponds to formula II in which x is equal to 1 and R7 is chosen from a C1-C6 alkyl radical; a C1-C6 monohydroxyalkyl radical; a C2-C6 polyhydroxy-alkyl radical; a C1-C6 aminoalkyl radical, a C1-C6 aminoalkyl radical whose amine is mono- or di-substited with a (C1-C6)alkyl, (C1-C6)alkylcarbonyl, amido or a (C1-C6)alkylsulphonyl radical; a C1-C6 carbamylalkyl radical, a tri(C1-C6)alkylsilane(C1-C6)alkyl radical; a (C1-C6)alkylcarboxy(C1-C6)alkyl radical; a (C1-C6)alkylcarbonyl(C1-C6)alkyl radical; an N—(C1-C6)alkylcarbamyl(C1-C6)alkyl radical; R4 with R5 together form an azetidine, pyrrolidine, piperidine, piperazine or morpholine ring, R6 being chosen in this case from a C1-C6 alkyl radical; a C1-C6 monohydroxyalkyl radical; a C2-C6 polyhydroxyl alkyl radical; a C1-C6 aminoalkyl radical; a C1-C6 aminoalkyl radical whose amine is mono- or di-substituted with a (C1-C6)alkyl, (C1-C6)alkylcarbonyl, amido or (C1-C6)alkylsulphonyl radical; a C1-C6 carbamylalkyl radical; a tri(C1-C6)alkylsilane(C1-C6)alkyl radical; a (C1-C6)alkylcarboxy(C1-C6)alkyl radical; a (C1-C6)alkylcarbonyl(C1-C6)alkyl radical; an N—(C1-C6)alkylcarbamyl(C1-C6)alkyl radical.
- 10. The composition of claim 7, wherein the cationic tertiary para-phenylenediamine is such that D is a single bond or an alkylene chain which may be substituted.
- 11. The composition of claim 7, wherein the cationic tertiary para-phenylenediamine is such that R2 is a trialkylammonium radical.
- 12. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that R2 represents the onium radical Z corresponding to formula III
- 13. The composition of claim 12, wherein the cationic tertiary para-phenylenediamine is such that the vertices E, G, J and L form an imidazole ring.
- 14. The composition of claim 12, wherein the cationic tertiary para-phenylenediamine is such that x is equal to 0, D is a single bond or an alkylene chain which may be substituted.
- 15. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that R2 represents an onium radical Z corresponding to formula IV
- 16. The composition of claim 15, wherein the vertices E, G, J, L and M form, with the nitrogen of the ring, a ring chosen from pyridine and pyrimidine rings.
- 17. The composition of claim 15, wherein the cationic tertiary para-phenylenediamine is such that x is equal to 0 and R11 is chosen from a hydroxyl radical, a C1-C6 alkyl radical, a C1-C6 monohydroxyalkyl radical, a C2-C6 polyhydroxyalkyl radical, a C1-C6 alkoxy radical, a tri(C1-C6)alkylsilane(C1-C6)alkyl radical, an amido radical, a C1-C6 alkylcarbonyl radical, an amino radical, an amino radical which is mono- or di-substituted with a (C1-C6)alkyl, a (C1-C6)alkylcarbonyl, amido or (C1-C6)alkylsulphonyl radical; a C1-C6 monohydroxyalkyl radical or a C2-C6 polyhydroxyalkyl radical and R12 is chosen from a C1-C6 alkyl radical, a C1-C6 monohydroxyalkyl radical, a C2-C6 polyhydroxyalkyl radical, a tri(C1-C6)alkylsilane(C1-C6)alkyl radical, a (C1-C6)alkoxy(C1-C6)alkyl radical, a C1-C6 carbamylalkyl radical.
- 18. The composition of claim 15, wherein the cationic tertiary para-phenylenediamine is such that x is equal to 1 and R13 is chosen from a C1-C6 alkyl radical; a C1-C6 monohydroxyalkyl radical; a C2-C6 polyhydroxyalkyl radical; a C1-C6 aminoalkyl radical, a C1-C6 aminoalkyl radical whose amine is mono- or di-substituted with a (C1-C6)alkyl radical, a (C1-C6)alkylcarbonyl radical, an amido radical, a (C1-C6)alkylsulphonyl radical; a C1-C6 carbamylalkyl radical; a tri(C1-C6)alkylsilane(C1-C6)alkyl radical; a (C1-C6)alkylcarbonyl(C1-C6)alkyl radical; an N—(C1-C6)alkylcarbamyl(C1-C6)alkyl radical; R11 is chosen from a hydroxyl radical, a C1-C6 alkyl radical, a C1-C6 monohydroxyalkyl radical, a C2-C6 polyhydroxyalkyl radical, a C1-C6 alkoxy radical, a tri(C1-C6)alkylsilane(C1-C6)alkyl radical, an amido radical, a C1-C6 alkylcarbonyl radical, an amino radical, an amino radical which is mono- or di-substituted with a (C1-C6)alkyl, (C1-C6)alkylcarbonyl, amido or (C1-C6)alkylsulphonyl radical; and R12 is chosen from a C1-C6 alkyl radical, a C1-C6 monohydroxyalkyl radical, a C2-C6 polyhydroxyalkyl radical, a tri(C1-C6)alkylsilane(C1-C6)alkyl radical, a (C1-C6)alkoxy(C1-C6)alkyl radical, a C1-C6 carbamylalkyl radical.
- 19. The composition of claim 15, wherein the cationic tertiary para-phenylenediamine is such that R11, R12 and R13 are alkyl radicals which may be substituted.
- 20. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that the radical R2 is the radical of formula —XP(O)(O—)OCH2CH2N+(CH3)3 where X represents an oxygen atom or a radical —NR14, R14 representing a hydrogen, a C1-C4 alkyl radical or a hydroxyalkyl radical.
- 21. The composition of claim 2, wherein the cationic tertiary para-phenylenediamine is such that R2 is a guanidine radical of formula —X—C═NR8—NR9R10, X represents an oxygen atom or a radical —NR11, R8, R9, R10 and R11 representing a hydrogen, a C1-C4 alkyl radical or a C1-C4 hydroxyalkyl radical.
- 22. The composition of claim 1, wherein the cationic tertiary para-phenylene is chosen from the group consisting of:
[1-(4-Aminophenyl)pyrrolidin-3-yl]trimethylammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]dimethyltetradecylammonium bromide, N′-[1-(4-Aminophenyl)pyrrolidin-3-yl]-N,N-dimethyl-guanidinium choride, N-[1-(4-Aminophenyl)pyrrolidin-3-yl]guanidinium choride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]-(2-hydroxyethyl)dimethyl-ammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]dimethyl-(3-trimethylsilanylpropyl)ammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]-(trimethylammonium-hexyl)dimethylammonium dichloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]oxophosphorylcholine, {2-[1-(4-Aminophenyl)pyrrolidin-3-yloxy]ethyl}trimethylammonium chloride, 1-{2-[1-(4-Aminophenyl)pyrrolidin-3-yloxy]ethyl}-1-methyl-pyrrolidinium chloride, 3-{3-[1-(4-Aminophenyl)pyrrolidin-3-yloxy]propyl}-1-methyl-3H-imidazol-1-ium chloride, 1-{2-[1-(4-Aminophenyl)pyrrolidin-3-yloxy]ethyl}-1-methyl-piperidinium chloride, 3-{3-[1-(5-trimethylsilanylethyl-4-Amino-3-trimethylsilanylethylphenyl)pyrrolidin-3-yloxy]propyl}-1-methyl-3H-imidazol-1-um chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]trimethyammonium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]dimethyl-tetradecylammonium chloride, N′-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-N,N-dimethyl guanidinium choride, N-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]guanidinium choride, 3-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-(2-hydroxy-ethyl)dimethylammonium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]dimethyl-(3-trimethylsilanylpropylammonium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-(trimethylammoniumhexyl-dimethylammonium dichloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]oxophosphorylcholine, {2-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yloxy]ethyl}trimethylammonium chloride, 1-{2-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yloxy]ethyl}-1-methylpyrrolidinium chloride, 3-{3-[1-(4-Amino-3r-methylphenyl)pyrrolidin-3-yloxy]-propyl}1-methyl-3H-imidazol-1-um chloride, 1-{2-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yloxy]ethyl}-1-methylpiperidinium chloride, [1-(4-Amino-3-trimethylsilanylethylphenyl)pyrrolidin-3-yl]trimethylammonium chloride, 3-[1-(4-Amino-3-trimethylsilanylethylphenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, 3-{3-[1-(4-Amino-3-trimethylsilanylethylphenyl)pyrrolidin-3-yloxy]propyl}-1-methyl-3H-imidazol-1-um chloride, [1-(5-trimethylsilanylethyl-4-Amino-3-trimethylsilanylethyl-phenyl)pyrrolidin-3-yl]trimethylammonium chloride, 3-[1-(5-trimethylsilanylethyl-4-Amino-3-trimethylsilanylethyl-phenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, 1′-(4-Aminophenyl)-1-methyl-[1,3′]bipyrrolidinyl-1-ium chloride, 1′-(4-Amino-3-methylphenyl)-1-methyl-[1,3′]bipyrrolidinyl-1-ium chloride, 3-{[1-(4-Aminophenyl)pyrrolidin-3-ylcarbamoyl]methyl}-1-methyl-3H-imidazol-1-ium chloride, 3-{[1-(4-Amino-3-methylphenyl)pyrrolidin-3-ylcarbamoyl]methyl}-1-methyl-3H-imidazol-1-ium chloride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-(3-trimethylsilanylpropyl)-3H-imidazol-1-ium chloride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-(3-trimethylsilanylpropyl)-3H-imidazol-1-ium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]ethyldimethylammonium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]ethyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium bromide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium methosulphate, [1-(4-aminophenyl)pyrrolidin-3-yl]butyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]pentyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hexyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]heptyldimethylammonium iodide, [1-(4-Aminophenyl)pyrrolidin-3-yl]octyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]decyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hexadecyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hydroxyethyldimethylammonium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]hydroxyethyldimethylammonium iodide.
- 23. The composition of claim 1, wherein the cationic tertiary para-phenylene is chosen from the group consisting of [1-(4-Aminophenyl)pyrrolidin-3-yl]trimethylammonium chloride;
[1-(4-Aminophenyl)pyrrolidin-3-yl]dimethyltetradecylammonium bromide, N′-[1-(4-Aminophenyl)pyrrolidin-3-yl]-N,N-dimethyl guanidinium choride, N-[1-(4-Aminophenyl)pyrrolidin-3-yl]guanidinium choride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl](2-hydroxyethyl)dimethyl-ammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]dimethyl-(3-trimethyl-silanylpropyl)ammonium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]trimethylammonium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]dimethyl-tetradecylammonium chlorides N′-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-N,N-dimethyl guanidinium choride, N-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]guanidinium choride, 3-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-(2-hydroxy-ethyl)dimethylammonium chloride, [1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]dimethyl-(3-trimethylsilanylpropylammonium chloride, 1′-(4-Aminophenyl)-1-methyl-[1,3′]bipyrrolidinyl-1-ium chloride, 1′-(4-Amino-3-methylphenyl)-1-methyl-[1,3′]bipyrrolidinyl-1-ium chloride, 3-{[1-(4-Aminophenyl)pyrrolidin-3-ylcarbamoyl]methyl}-1-methyl-3H-imidazol-1-ium chloride, 3-{[1-(4-Amino-3-methylphenyl)pyrrolidin-3-ylcarbamoyl]methyl}-1-methyl-3H- imidazol-1-ium chloride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-(3-trimethylsilanylpropyl)-3H-imidazol-1-ium chloride, 3-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-1-(3-trimethylsilanyl-propyl)-3H-imidazol-1-ium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]ethyldimethylammonium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]ethyldimethylammonium iodide, [1-(4-Aminophenyl)pyrrolidin-3-yl]propyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium bromide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium methosulphate, [1-(4-aminophenyl)pyrrolidin-3-yl]butyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]pentyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hexyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]heptyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]octyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]decyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hexadecyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hydroxyethyldimethylammonium chloride, and [1-(4-aminophenyl)pyrrolidin-3-yl]hydroxyethyldimethylammonium iodide.
- 24. The composition of claim 1, wherein the cationic tertiary para-phenylene is chosen from the group consisting of:
[1-(4-Aminophenyl)pyrrolidin-3-yl]trimethylammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]dimethyltetradecylammonium bromide, N′-[1-(4-Aminophenyl)pyrrolidin-3-yl]-N,N-dimethyl guanidinium choride, N-[1-(4-Aminophenyl)pyrrolidin-3-yl]guanidinium choride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]-(2-hydroxyethyl)-dimethylammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]dimethyl-(3-trimethylsilanylpropyl)ammonium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]-(trimethylammonium-hexyl)dimethylammonium dichloride, 1′-(4-Aminophenyl)-1-methyl-[1,3′]bipyrrolidinyl-1-ium chloride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-(3-trimethylsilanylpropyl)-3H-imidazol-1-ium chloride, 3-[1-(4-Amino-3-methylphenyl)pyrrolidin-3-yl]-1-(3-trimethylsilanylpropyl)-3H-imidazol-1-ium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]ethyldimethylammonium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]ethyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethylammonium bromide, [1-(4-aminophenyl)pyrrolidin-3-yl]propyldimethyl ammonium methosulphate, [1-(4-aminophenyl)pyrrolidin-3-yl]butyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]pentyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hexyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]heptyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]octyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]decyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hexadecyldimethylammonium iodide, [1-(4-aminophenyl)pyrrolidin-3-yl]hydroxyethyldimethylammonium chloride, [1-(4-aminophenyl)pyrrolidin-3-yl]hydroxyethyldimethylammonium iodide.
- 25. The composition of claim 1, wherein the cationic tertiary para-phenylene is chosen from the group consisting of:
[1-(4-Aminophenyl)pyrrolidin-3-yl]trimethylammonium chloride, 3-[1-(4-Aminophenyl)pyrrolidin-3-yl]-1-methyl-3H-imidazol-1-ium chloride, [1-(4-Aminophenyl)pyrrolidin-3-yl]-(2-hydroxyethyl)dimethyl-ammonium chloride, 1′-(4-Aminophenyl)-1-methyl-[1,3′]bipyrrolidinyl-1-ium chloride.
- 26. The composition of claim 1, wherein the cationic tertiary para-phenylene is chosen from the group consisting of:
[1-(4-Aminophenyl)pyrrolidin-3-yl]trimethylammonium chloride, and [1-(4-Aminophenyl)pyrrolidin-3-yl]-(2-hydroxy-ethyl)dimethylammonium chloride.
- 27. The composition of claim 1, wherein the non-cationic tertiary para-phenylenediamine corresponds to the compounds of general formula (V) and their addition salts with an acid:
- 28. The composition of claim 27, wherein the tertiary para-phenylenediamine not containing a pyrrolidine ring is N,N-bis(β-hydroxyethyl)-p-phenylenediamine.
- 29. The composition of claim 1, wherein the non-cationic tertiary para-phenylenediamines represent from 0.001 to 15% by weight relative to the total weight of the composition.
- 30. The composition of claim 1, wherein the benzomorpholine coupler corresponds to the compounds of formula (V′) and their addition salts with an acid:
- 31. The composition of claim 30, wherein the benzomorpholine coupler corresponds to the compounds of formula (V′), and their addition salts with an acid, in which X represents an oxygen atom (O).
- 32. The composition of claim 30, wherein the coupler is chosen from benzomorpholine, 7-hydroxybenzomorpholine, 7-aminobenzomorpholine, 6-hydroxybenzomorpholine, 6-aminobenzomorpholine, 5-hydroxybenzomorpholine, 5-aminobenzomorpholine, 1-methyl-7-hydroxybenzomorpholine, 2-methyl-7-hydroxybenzomorpholine, 5-hydroxy-7-methylbenzomorpholine.
- 33. The composition of claim 32, wherein the benzomorpholine coupler is 6-hydroxybenzomorpholine.
- 34. The composition of claim 1, wherein the benzomorpholine coupler(s) represent from 0.001 to 15%, and preferably from 0.05 to 10% by weight relative to the total weight of the composition.
- 35. The composition of claim 1, wherein the composition further comprises at least one colorant chosen from the para-aminophenols of formula (V″) and their addition salts
- 36. The composition of claim 35, wherein the para-aminophenol of formula (V″) is chosen from para-aminophenol, 4-amino-3-methylphenol, 4-amino-3-fluorophenol, 4-amino-3-hydroxymethylphenol, 4-amino-2-methylphenol, 4-amino-2-hydroxymethylphenol, 4-amino-2-methoxymethylphenol, 4-amino-2-aminomethylphenol, 4-amino-2-(β-hydroxyethylaminomethyl)phenol, 4-amino-2-fluorophenol, N-methyl-para-aminophenol and their addition salts.
- 37. The composition of claim 35, wherein the heterocyclic coupler of formula (V′″) is chosen from 6-hydroxyindole, 6-hydroxy-3-methoxycarbonylindole, 6-hydroxy-1 -methyl-3-methoxycarbonylindole, 6-hydroxy-1-methyl-2,3-dimethoxycarbonylindole, 6-hydroxy-1,2-dimethylindole, 6-hydroxy-2-methylindole, 6-hydroxy-2-carboxy-indole, 6-hydroxy-2,3-dimethylindole, 6-hydroxy-3-carboxyindole, 6-hydroxy-3-ethoxycarbonylindole, 6-hydroxy-2-ethoxycarbonylindole, 6-hydroxy-3-methylindole, 6-hydroxy-1-methylindole, 7-hydroxyindole, 7-hydroxy-3-methylindole.
- 38. The composition of claim 37, wherein the heterocyclic coupler of formula (V′″) is 6-hydroxyindole.
- 39. The composition of claim 35, wherein the compounds of formulae (V″) and/or (V′″) represent from 0.0001 to 10% by weight relative to the total weight of the composition.
- 40. The composition of claim 1, wherein the cationic tertiary para-phenylenediamine(s) having a pyrrolidine ring represent from 0.001 to 10% by weight relative to the total weight of the composition.
- 41. The composition of claim 1, wherein the composition further comprises at least one cationic polymer.
- 42. The composition of claim 1, wherein the composition further comprises at least one thickening polymer.
- 43. The composition of claim 1, wherein the composition further comprises at least one surfactant chosen from the group consisting of anionic surfactants, amphoteric or zwitterionic surfactants, nonionic surfactants and cationic surfactants.
- 44. The composition of claim 1, wherein the composition further comprises at least one additional oxidation base chosen from para-phenylenediamines, bis-phenylalkylenediamines, ortho-aminophenols, heterocyclic bases and their addition salts.
- 45. The composition of 44, wherein the additional oxidation base(s) are present in a quantity of between 0.001 to 20% by weight relative to the total weight of the composition.
- 46. The composition of claim 1, wherein the composition further comprises at least one additional coupler chosen from meta-phenylenediamines, meta-aminophenols, meta-diphenols, naphthalene couplers, heterocyclic couplers and their addition salts.
- 47. The composition of claim 46, wherein the coupler is chosen from 1,3-dihydroxybenzene, 1,3-dihydroxy-2-methylbenzene, 4-chloro-1,3-dihydroxybenzene, 2,4-diamino-1-(β-hydroxyethyloxy)benzene, 2-amino-4-(β-hydroxyethylamino)-1-methoxybenzene, 1,3-diaminobenzene, 1,3-bis(2,4-diaminophenoxy)propane, 3-ureidoaniline, 3-ureido-1-dimethylaminobenzene, sesamol, 1-β-hydroxyethylamino-3,4-methylenedioxybenzene, c-naphthol, 2-methyl-1-naphthol, 4-hydroxyindole, 4-hydroxy-N-methylindole, 2-amino-3-hydroxypyridine, 3,5-diamino-2,6-dimethoxypyridine, 1-N-(β-hydroxyethyl)amino-3,4-methylenedioxybenzene, 2,6-bis(β-hydroxyethylamino)toluene and their addition salts.
- 48. The composition of claim 46, wherein the additional coupler(s) are present in a quantity of between 0.001 and 20%, by weight relative to the total weight of the composition.
- 49. The composition of claim 1, wherein the composition further comprises at least one direct dye.
- 50. The composition of claim 1, wherein the composition further comprises at least one hydroxylated solvent such as ethanol, propylene glycol, glycerol, polyol monoethers.
- 51. The composition of claim 1, wherein the composition further comprises an oxidizing agent chosen from hydrogen peroxide, urea peroxide, alkali metal bromates, persalts, peracids and oxidase enzymes, and preferably hydrogen peroxide.
- 52. A method for the oxidation dyeing of keratinous fibres such as hair, wherein a dyeing composition as defined in claim 1 is applied to the fibres in the presence of an oxidizing agent.
- 53. A multicompartment device in which a first compartment contains a dyeing composition for dyeing keratinous fibres, as defined in claim 1, and a second compartment contains an oxidizing agent.
Priority Claims (1)
Number |
Date |
Country |
Kind |
02/15774 |
Dec 2002 |
FR |
|
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to French Application No. 02/15774 filed 13 Dec. 2003, and further claims the benefit of U.S. Provisional Application No. 60/450,331 filed 28 Feb. 2003, the entire disclosures of which are incorporated herein by reference in their entirety.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60450331 |
Feb 2003 |
US |